共 7 条
[1]
P-glycoprotein modulates ceramide-med-iated sensitivity of human breast cancer cells to tubulin-bindinganticancer drugs. Shabbits JA,Mayer LD. Molecular Cancer Therapeutics . 2002
[2]
Mrp1 multidrug resistance-asso-ciated protein and P-glycoprotein expression in rat brain mi-crovessel endothelial cells. Regina A,Koman A,Piciotti M,El Hafny B,Center MS,Berg-mann R,Couraud PO,Roux F. Journal of Neurochemistry . 1998
[3]
Developmentand characterization of a rat brain capillary endothelial culture:towards an in vitro blood-brain barrier. Abbott NJ,Hughes CC,Revest PA,Greenwood J. Journal of Cell Science . 1992
[4]
Disruption of the mousemdr1aP-Glycoprotein gene leads to a deficiency in the blood-brain barrier and to increasedsensitivity to drugs. Schinkel AH,Smit JJM,Tellingen OV. Cell . 1994
[5]
Relationship of octanol/water partition coefficient andmolecular weight to rat brain capillary permeability. Levin V. Journal of Medicinal Chemistry . 1980
[6]
Anti-CD19 antibodies inhibitthe function of the P-gp pumpin multidrug-resistant Blymphomacells. Ghetie MA,Ghetie V,Vitetta ES. Clinical Cancer Research . 1999
[7]
Increasein doxorubicincytotoxicity byinhibition of P-glycoprotein activity with Lomeriz-ine. Shiraki N,Hamada A,Ohmura T,et al. Biological and Pharmaceutical Bulletin . 2001